DENDRITIC CELL THERAPY RGCC
LIVE

Serial Number

79442592

Owner

R.G.C.C. Holdings AG

Attorney

James R Menker

Filing Date

Sep 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DENDRITIC CELL THERAPY RGCC Trademark

Serial Number: 79442592 • Registration: 8320217

DENDRITIC CELL THERAPY RGCC is a trademark filed by R.G.C.C. Holdings AG on September 11, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

R.G.C.C. Holdings AG (80 trademarks)

Baarerstrasse 95

Entity Type: 25

Trademark Details

Filing Date

September 11, 2025

Registration Date

June 30, 2026

Published for Opposition

May 12, 2026

Goods & Services

Scientific research for medical purposes in the area of cancerous diseases, cancer treatment, immune response, immunotherapy, T cell therapy, and cell therapy

Pharmaceutical products for the treatment of cancer; Pharmaceutical products for immune response modification; Medical preparations for the treatment of cancer; Medical preparations for immune response modification; Pharmaceutical products for modulating immune response; Medical preparations for modulating immune response; Pharmaceutical products for immunotherapy, T cell therapy, and cell therapy; Medical preparations for immunotherapy, T cell therapy, and cell therapy

Medical diagnosis services, namely, medical analysis services for the diagnosis of cancer

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 30, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 30, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 13, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 13, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 13, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 13, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 13, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 11, 2026 TROA
REFUSAL PROCESSED BY IB
Mar 26, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 9, 2026 RFCS
REFUSAL PROCESSED BY MPU
Mar 9, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 9, 2026 RFCR
NON-FINAL ACTION WRITTEN
Feb 8, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 7, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 6, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 29, 2026 REPR